IL6 and COVID-19: These data emphasize alternative potential mechanisms for the induction of AT1R-Ab following COVID-19, including endothelial damage [2, 3, 11], inflammation or cytokine (particularly IL-6) triggered induction [12–14], or genetic predisposition such as carriage of the DRB1*04 allele [19].